| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5955488 | SANDOZ | Freeze-dried compositions |
Nov, 2015
(8 years ago) | |
| US6063802 | SANDOZ | Ondansetron freeze-dried dosage form compositions for oral administration |
Nov, 2015
(8 years ago) | |
|
US5955488 (Pediatric) | SANDOZ | Freeze-dried compositions |
May, 2016
(7 years ago) | |
|
US6063802 (Pediatric) | SANDOZ | Ondansetron freeze-dried dosage form compositions for oral administration |
May, 2016
(7 years ago) | |
Zofran Odt is owned by Sandoz.
Zofran Odt contains Ondansetron.
Zofran Odt has a total of 4 drug patents out of which 4 drug patents have expired.
Expired drug patents of Zofran Odt are:
- US5955488
- US6063802
- US5955488*PED
- US6063802*PED
Zofran Odt was authorised for market use on 27 January, 1999.
Zofran Odt is available in tablet, orally disintegrating;oral dosage forms.
The generics of Zofran Odt are possible to be released after 14 May, 2016.
Drugs and Companies using ONDANSETRON ingredient
Market Authorisation Date: 27 January, 1999
Treatment: NA
Dosage: TABLET, ORALLY DISINTEGRATING;ORAL
How can I launch a generic of ZOFRAN ODT before it's drug patent expiration?
More Information on Dosage
ZOFRAN ODT family patents
